J1575 HCPCS code: Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
J1575 is the HCPCS Level II code for injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin. In 2024 Medicare paid an average of $13.39 per service for J1575 across 831,182 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 3000 per day on DME suppliers. Medicare volume rose 7% from 2022 to 2024 (775,301 to 831,182 services). In 2024, 181 suppliers billed Medicare for J1575 (purchases), serving 872 beneficiaries; Florida, Texas, New York accounted for 33% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2016-01-01 |
| Last action effective | 2016-01-01 |
Who bills J1575 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 181 |
| Referring clinicians | 652 |
| Medicare beneficiaries | 872 |
| States with claims | 46 |
| Share of services in top 3 states (Florida, Texas, New York) | 33% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 179 | 822 |
| 2023 | 176 | 826 |
| 2024 | 181 | 872 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1575, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 775,301 | 247 | $15.37 | $12.27 |
| 2023 | 799,520 | 260 | $16.07 | $12.79 |
| 2024 | 831,182 | 270 | $16.82 | $13.39 |
States with the most J1575 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Tennessee | 172,925 | $13.45 |
| Texas | 156,900 | $13.46 |
| New York | 82,017 | $13.41 |
| New Jersey | 71,601 | $13.48 |
| Florida | 67,350 | $13.46 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 3000 | Prescribing Information |
| outpatient hospital claims | 3000 | Prescribing Information |
| practitioner claims | 3000 | Prescribing Information |
Medicare policy articles for this code
- A52507: External Infusion Pumps - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance
- A56786: Billing and Coding: Immune Globulin (Novitas Solutions, Inc. (MAC - Part A, MAC - Part B))
- A57554: Billing and Coding: Immune Globulins (WPS Insurance Corporation (MAC - Part A, MAC - Part B))
- A57778: Billing and Coding: Immune Globulin (First Coast Service Options, Inc. (MAC - Part A, MAC - Part B))
Covered diagnoses (1,631 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| D80.0 | Hereditary hypogammaglobulinemia | 4 |
| D80.2 | Selective deficiency of immunoglobulin A [IgA] | 4 |
| D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses | 4 |
| D80.4 | Selective deficiency of immunoglobulin M [IgM] | 4 |
| D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] | 4 |
| D80.6 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia | 4 |
| D80.7 | Transient hypogammaglobulinemia of infancy | 4 |
| D81.0 | Severe combined immunodeficiency [SCID] with reticular dysgenesis | 4 |
| D81.1 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers | 4 |
| D81.2 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers | 4 |
Showing 10 of 1,631. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J1575
- 2016-01-01: J1575 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1575?
J1575 is the HCPCS Level II code for injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin. Short descriptor: "Hyqvia 100mg immuneglobulin".
How much does Medicare pay for J1575?
In 2024, the average Medicare payment was $13.39 per service (average allowed $16.82).
Does Medicare cover J1575?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for J1575?
Medicare policy articles that cite J1575 list 1,631 covered ICD-10-CM diagnosis codes across 4 articles. The most cited include D80.0 (Hereditary hypogammaglobulinemia), D80.2 (Selective deficiency of immunoglobulin A [IgA]), D80.3 (Selective deficiency of immunoglobulin G [IgG] subclasses). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J1575 can be billed per day?
3000 on DME suppliers; 3000 on outpatient hospital claims; 3000 on practitioner claims (NCCI medically unlikely edits).
Related J15 codes
- J1551 — Injection, immune globulin (cutaquig), 100 mg
- J1552 — Injection, immune globulin (alyglo), 500 mg
- J1553 — Injection, immune globulin (yimmugo), 100 mg
- J1554 — Injection, immune globulin (asceniv), 500 mg
- J1555 — Injection, immune globulin (cuvitru), 100 mg
- J1556 — Injection, immune globulin (bivigam), 500 mg
- J1557 — Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1558 — Injection, immune globulin (xembify), 100 mg
- J1559 — Injection, immune globulin (hizentra), 100 mg
- J1560 — Injection, gamma globulin, intramuscular, over 10 cc
- J1561 — Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1562 — Injection, immune globulin (vivaglobin), 100 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1575
- Watch J1575 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1575
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.